201 related articles for article (PubMed ID: 18477212)
1. Loss of heterozygosity of DNA repair gene, hOGG1, in renal cell carcinoma but not in renal papillary adenoma.
Gokden N; Li L; Zhang H; Schafer RF; Schichman S; Scott MA; Smoller BR; Fan CY
Pathol Int; 2008 Jun; 58(6):339-43. PubMed ID: 18477212
[TBL] [Abstract][Full Text] [Related]
2. Concordant loss of heterozygosity of DNA repair gene, hOGG1, in melanoma in situ and atypical melanocytic hyperplasia.
Pashaei S; Li L; Zhang H; Spencer HJ; Schichman SA; Fan CY; Smoller BR
J Cutan Pathol; 2008 Jun; 35(6):525-31. PubMed ID: 18312439
[TBL] [Abstract][Full Text] [Related]
3. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
4. Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma.
Wang KL; Weinrach DM; Luan C; Han M; Lin F; Teh BT; Yang XJ
Hum Pathol; 2007 Feb; 38(2):239-46. PubMed ID: 17056094
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations in papillary thyroid carcinoma and hashimoto thyroiditis: An analysis of hOGG1 loss of heterozygosity.
Royer MC; Zhang H; Fan CY; Kokoska MS
Arch Otolaryngol Head Neck Surg; 2010 Mar; 136(3):240-2. PubMed ID: 20231640
[TBL] [Abstract][Full Text] [Related]
6. Genetic changes of the E-cadherin and APC tumour suppressor genes in clear cell renal cell carcinoma.
Pećina-SLaus N; Gall-TroSelj K; SLaus M; Radić K; NikuSeva-Martić T; Pavelić K
Pathology; 2004 Apr; 36(2):145-51. PubMed ID: 15203750
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.
Lv D; Zhao W; Dong D; Qian XP; Zhang Y; Tian XJ; Zhang J
Eur J Cancer; 2011 Sep; 47(13):2068-76. PubMed ID: 21600761
[TBL] [Abstract][Full Text] [Related]
9. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
el-Naggar AK; Batsakis JG; Wang G; Lee MS
Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
[TBL] [Abstract][Full Text] [Related]
10. Distribution of subtypes of metastatic renal-cell carcinoma: correlating findings of fine-needle aspiration biopsy and surgical pathology.
Mai KT; Alhalouly T; Lamba M; Yazdi HM; Stinson WA
Diagn Cytopathol; 2003 Feb; 28(2):66-70. PubMed ID: 12561022
[TBL] [Abstract][Full Text] [Related]
11. Evolving classification of renal cell neoplasia.
Delahunt B; Velickovic M; Grebe SK
Expert Rev Anticancer Ther; 2001 Dec; 1(4):576-84. PubMed ID: 12113090
[TBL] [Abstract][Full Text] [Related]
12. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
Velickovic M; Delahunt B; Störkel S; Grebem SK
Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
[TBL] [Abstract][Full Text] [Related]
13. Concomitant loss of mitochondria and the DNA repair protein hOGG1 in clear cell carcinoma of the kidney.
Mukunyadzi P; Huang H; Liu K; Fan CY
Appl Immunohistochem Mol Morphol; 2003 Dec; 11(4):334-8. PubMed ID: 14663360
[TBL] [Abstract][Full Text] [Related]
14. Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma.
Brunelli M; Eble JN; Zhang S; Martignoni G; Cheng L
Mod Pathol; 2003 Oct; 16(10):1060-3. PubMed ID: 14559991
[TBL] [Abstract][Full Text] [Related]
15. Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma.
Schraml P; Müller D; Bednar R; Gasser T; Sauter G; Mihatsch MJ; Moch H
J Pathol; 2000 Mar; 190(4):457-61. PubMed ID: 10699995
[TBL] [Abstract][Full Text] [Related]
16. Deletion mapping of 18q in conventional renal cell carcinoma.
Hirata H; Matsuyama H; Matsumoto H; Korenaga Y; Ohmi C; Sakano S; Yoshihiro S; Naito K
Cancer Genet Cytogenet; 2005 Dec; 163(2):101-5. PubMed ID: 16337851
[TBL] [Abstract][Full Text] [Related]
17. [Loss of heterozygosity in the 9p21 region as an inactivation mechanism of the p16 suppressor gene].
Maestro de las Casas ML; Sanz-Casla MT; del Barco V; Moreno J; Zanna I; Redondo E; Fernández C; Izquierdo L; Resel Estévez L
Arch Esp Urol; 2000 Sep; 53(7):603-9. PubMed ID: 11037653
[TBL] [Abstract][Full Text] [Related]
18. Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinoma.
Kaku H; Ito S; Ebara S; Ouchida M; Nasu Y; Tsushima T; Kumon H; Shimizu K
Urology; 2004 Jul; 64(1):176-81. PubMed ID: 15245966
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes.
Nagy A; Buzogany I; Kovacs G
Histopathology; 2004 Jun; 44(6):542-6. PubMed ID: 15186268
[TBL] [Abstract][Full Text] [Related]
20. Multifocal renal cell carcinoma: evidence for a common clonal origin.
Miyake H; Nakamura H; Hara I; Gohji K; Arakawa S; Kamidono S; Saya H
Clin Cancer Res; 1998 Oct; 4(10):2491-4. PubMed ID: 9796982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
